DAVID W SCOTT
Broker in Somerville, MA
License number
Massachusetts 9018330
Issued Date
Aug 1, 1996
Expiration Date
Jul 6, 2003
Type
Salesperson
Address
Address
Somerville, MA 02143
Professional information
Chemical Compounds-149
US Patent:
2008031, Dec 18, 2008
Filed:
Dec 19, 2006
Appl. No.:
12/097652
Inventors:
Brian Aquila - Marlborough MA, US
Donald Cook - Derry NH, US
Leslie Dakin - Natick MA, US
Stephanos Ioannidis - Watertown MA, US
Paul Lyne - Arlington MA, US
David Scott - Somerville MA, US
Xiaolan Zheng - Waltham MA, US
Donald Cook - Derry NH, US
Leslie Dakin - Natick MA, US
Stephanos Ioannidis - Watertown MA, US
Paul Lyne - Arlington MA, US
David Scott - Somerville MA, US
Xiaolan Zheng - Waltham MA, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/427, C07D 277/46, A61K 31/426, A61P 35/00, C07D 417/02
US Classification:
5142102, 548195, 514371
Abstract:
The invention relates to chemical compounds, or pharmaceutically acceptable salts thereof of the formula which possess CSF 1R kinase inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
Pyrazolyl-Amino-Substituted Pyrimidines And Their Use In The Treatment Of Cancer
US Patent:
2008019, Aug 14, 2008
Filed:
May 4, 2006
Appl. No.:
11/913451
Inventors:
David Scott - Somerville MA, US
Haixia Wang - West Newton MA, US
Tao Wang - Sudbury MA, US
Haixia Wang - West Newton MA, US
Tao Wang - Sudbury MA, US
Assignee:
ASTRAZENECA - Södertälje
International Classification:
A61K 31/506, C07D 403/12, A61P 35/04
US Classification:
514275, 544297
Abstract:
This invention relates to novel compounds having the formula (I), and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.